作者
- Antman, E.M. (15)
- Braunwald, E. (20)
- Cannon, C.P. (14)
- Gibson, C.M. (16)
- Giugliano, R.P. (7)
- McCabe, C.H. (16)
- Morrow, D.A. (21)
- Murphy, S.A. (9)
- Sabatine, M.S. (33)
- de Lemos, J.A. (8)
|
總筆數:33
| 篇名 | 作者 | 刊名 | 出版年 | 查看 |
|---|
| Identification of patients at high risk for death and cardiac ischemicevents after hospital discharge |
Sabatine, M.S.;McCabe, C.H.;Morrow, D.A.;Giugliano, R.P.;de Lemos, J.A.;Cohen, M.;Antman, E.M.;Braunwald, E.; |
American Heart Journal |
2002-06-01 |
查看 |
| Identification of patients at high risk for death and cardiac ischemicevents after hospital discharge |
Sabatine, M.S.;McCabe, C.H.;Morrow, D.A.;Giugliano, R.P.;de Lemos, J.A.;Cohen, M.;Antman, E.M.;Braunwald, E.; |
American Heart Journal |
2002-06-01 |
查看 |
| Identification of patients at high risk for death and cardiac ischemicevents after hospital discharge |
Sabatine, M.S.;McCabe, C.H.;Morrow, D.A.;Giugliano, R.P.;de Lemos, J.A.;Cohen, M.;Antman, E.M.;Braunwald, E.; |
American Heart Journal |
2002-06-01 |
查看 |
| Identification of patients at high risk for death and cardiac ischemicevents after hospital discharge |
Sabatine, M.S.;McCabe, C.H.;Morrow, D.A.;Giugliano, R.P.;de Lemos, J.A.;Cohen, M.;Antman, E.M.;Braunwald, E.; |
American Heart Journal |
2002-06-01 |
查看 |
| Minimal ST-segment deviation: A simple, noninvasive method for identifyingpatients with a patent infarction-related artery after fibrinolyticadministration |
Cooper, H.A.;de Lemos, J.A.;Morrow, D.A.;Sabatine, M.S.;Murphy, S.A.;McCabe, C.H.;Gibson, C.M.;Antman, E.M.;Braunwald, E.; |
American Heart Journal |
2002-11-01 |
查看 |
| Minimal ST-segment deviation: A simple, noninvasive method for identifyingpatients with a patent infarction-related artery after fibrinolyticadministration |
Cooper, H.A.;de Lemos, J.A.;Morrow, D.A.;Sabatine, M.S.;Murphy, S.A.;McCabe, C.H.;Gibson, C.M.;Antman, E.M.;Braunwald, E.; |
American Heart Journal |
2002-11-01 |
查看 |
| Minimal ST-segment deviation: A simple, noninvasive method for identifyingpatients with a patent infarction-related artery after fibrinolyticadministration |
Cooper, H.A.;de Lemos, J.A.;Morrow, D.A.;Sabatine, M.S.;Murphy, S.A.;McCabe, C.H.;Gibson, C.M.;Antman, E.M.;Braunwald, E.; |
American Heart Journal |
2002-11-01 |
查看 |
| Minimal ST-segment deviation: A simple, noninvasive method foridentifying patients with a patent infarction-related artery afterfibrinolytic administration |
Cooper, H.A.;de Lemos, J.A.;Morrow, D.A.;Sabatine, M.S.;Murphy, S.A.;McCabe, C.H.;Gibson, C.M.;Antman, E.M.;Braunwald, E.; |
American Heart Journal |
2002-11-01 |
查看 |
| Design and rationale of Clopidogrel as Adjunctive ReperfusionTherapy-Thrombolysis in Myocardial Infarction (CLARITY-TIMI) 28 trial |
Sabatine, M.S.;McCabe, C.H.;Gibson, C.M.;Cannon, C.P.; |
American Heart Journal |
2005-02-01 |
查看 |
| Design and rationale of Clopidogrel as Adjunctive ReperfusionTherapy-Thrombolysis in Myocardial Infarction (CLARITY-TIMI) 28 trial |
Sabatine, M.S.;McCabe, C.H.;Gibson, C.M.;Cannon, C.P.; |
American Heart Journal |
2005-02-01 |
查看 |
| Design and rationale of Clopidogrel as Adjunctive ReperfusionTherapy-Thrombolysis in Myocardial Infarction (CLARITY-TIMI) 28 trial |
Sabatine, M.S.;McCabe, C.H.;Gibson, C.M.;Cannon, C.P.; |
American Heart Journal |
2005-02-01 |
查看 |
| Design and rationale of Clopidogrel as Adjunctive ReperfusionTherapy-Thrombolysis in Myocardial Infarction (CLARITY-TIMI) 28 trial |
Sabatine, M.S.;McCabe, C.H.;Gibson, C.M.;Cannon, C.P.; |
American Heart Journal |
2005-02-01 |
查看 |
| Correlation between the TIMI risk score and high-risk angiographic findingsin non-ST-elevation acute coronary syndromes: Observations from thePlatelet Receptor Inhibition in Ischemic Syndrome Management in PatientsLimited by Unstable Signs and Symptoms (PRISM-PLUS) trial |
Mega, J.L.;Morrow, D.A.;Sabatine, M.S.;Zhao, X.-Q.;Snapinn, S.M.;DiBattiste, P.M.;Gibson, C.M.;Antman, E.M.;Braunwald, E.;Theroux, P.; |
American Heart Journal |
2005-05-01 |
查看 |
| Correlation between the TIMI risk score and high-risk angiographicfindings in non-ST-elevation acute coronary syndromes: Observations fromthe Platelet Receptor Inhibition in Ischemic Syndrome Management inPatients Limited by Unstable Signs and Symptoms (PRISM-PLUS) trial |
Mega, J.L.;Morrow, D.A.;Sabatine, M.S.;Zhao, X.Q.;Snapinn, S.M.;DiBattiste, P.M.;Gibson, C.M.;Antman, E.M.;Braunwald, E.;Theroux, P.; |
American Heart Journal |
2005-05-01 |
查看 |
| Correlation between the TIMI risk score and high-risk angiographicfindings in non-ST-elevation acute coronary syndromes: Observations fromthe Platelet Receptor Inhibition in Ischemic Syndrome Management inPatients Limited by Unstable Signs and Symptoms (PRISM-PLUS) trial |
Mega, J.L.;Morrow, D.A.;Sabatine, M.S.;Zhao, X.Q.;Snapinn, S.M.;DiBattiste, P.M.;Gibson, C.M.;Antman, E.M.;Braunwald, E.;Theroux, P.; |
American Heart Journal |
2005-05-01 |
查看 |
| Combination of quantitative ST deviation and troponin elevationprovides independent prognostic and therapeutic information in unstableangina and non-ST-elevation myocardial infarction |
Sabatine, M.S.;Morrow, D.A.;McCabe, C.H.;Antman, E.M.;Gibson, C.M.;Cannon, C.P.; |
American Heart Journal |
2006-01-01 |
查看 |
| Combination of quantitative ST deviation and troponin elevationprovides independent prognostic and therapeutic information in unstableangina and non-ST-elevation myocardial infarction |
Sabatine, M.S.;Morrow, D.A.;McCabe, C.H.;Antman, E.M.;Gibson, C.M.;Cannon, C.P.; |
American Heart Journal |
2006-01-01 |
查看 |
| Predicting a late positive serum troponin in initiallytroponin-negative patients with non-ST-elevation acute coronary syndrome:Clinical predictors and validated risk score results from the TIMI IIIB andGUSTO IIA studies |
Januzzi, J.L.;Newby, L.K.;Murphy, S.A.;Pieper, K.;Antman, E.M.;Morrow, D.A.;Sabatine, M.S.;Ohman, E.M.;Cannon, C.P.;Braunwald, E.; |
American Heart Journal |
2006-02-01 |
查看 |
| Myeloid-related protein 8/14 and the risk of cardiovascular death ormyocardial infarction after an acute coronary syndrome in the Pravastatinor Atorvastatin Evaluation and Infection Theraphy: Thrombolysis inMyocardial Infarction (PROVE IT-TIMI 22) trial |
Morrow, D.A.;Wang, Y.;Croce, K.;Sakuma, M.;Sabatine, M.S.;Gao, H.;Pradhan, A.D.;Healy, A.M.;Buros, J.;McCabe, C.H.;Libby, P.;Cannon, C.P.;Braunwald, E.;Simon, D.I.; |
American Heart Journal |
2008-01-01 |
查看 |
| Effects of pretreatment with clopidogrel on nonemergent percutaneouscoronary intervention after fibrinolytic administration for ST-segmentelevation myocardial infarction: A Clopidogrel as Adjunctive ReperfusionTherapy-Thrombolysis in Myocardial Infarction (CLARITY-TIMI) 28 study |
for the TIMI Study Group;Gibson, C.M.;Murphy, S.A.;Pride, Y.B.;Kirtane, A.J.;Aroesty, J.M.;Stein, E.B.;Ciaglo, L.N.;Southard, M.C.;Sabatine, M.S.;Cannon, C.P.;Braunwald, E.; |
American Heart Journal |
2008-01-01 |
查看 |
| Myeloid-related protein 8/14 and the risk of cardiovascular death ormyocardial infarction after an acute coronary syndrome in the Pravastatinor Atorvastatin Evaluation and Infection Theraphy: Thrombolysis inMyocardial Infarction (PROVE IT-TIMI 22) trial |
Morrow, D.A.;Wang, Y.;Croce, K.;Sakuma, M.;Sabatine, M.S.;Gao, H.;Pradhan, A.D.;Healy, A.M.;Buros, J.;McCabe, C.H.;Libby, P.;Cannon, C.P.;Braunwald, E.;Simon, D.I.; |
American Heart Journal |
2008-01-01 |
查看 |
| Effects of pretreatment with clopidogrel on nonemergent percutaneouscoronary intervention after fibrinolytic administration for ST-segmentelevation myocardial infarction: A Clopidogrel as Adjunctive ReperfusionTherapy-Thrombolysis in Myocardial Infarction (CLARITY-TIMI) 28 study |
for the TIMI Study Group;Gibson, C.M.;Murphy, S.A.;Pride, Y.B.;Kirtane, A.J.;Aroesty, J.M.;Stein, E.B.;Ciaglo, L.N.;Southard, M.C.;Sabatine, M.S.;Cannon, C.P.;Braunwald, E.; |
American Heart Journal |
2008-01-01 |
查看 |
| Detection of myocardial injury in patients with unstable angina using anovel nanoparticle cardiac troponin I assay: Observations from thePROTECT-TIMI 30 Trial |
Wilson, S.R.;Sabatine, M.S.;Braunwald, E.;Sloan, S.;Murphy, S.A.;Morrow, D.A.; |
American Heart Journal |
2009-09-01 |
查看 |
| Detection of myocardial injury in patients with unstable angina using anovel nanoparticle cardiac troponin I assay: Observations from thePROTECT-TIMI 30 Trial |
Wilson, S.R.;Sabatine, M.S.;Braunwald, E.;Sloan, S.;Murphy, S.A.;Morrow, D.A.; |
American Heart Journal |
2009-09-01 |
查看 |
| Extent of ST-segment resolution after fibrinolysis adds improved riskstratification to clinical risk score for ST-segment elevation myocardialinfarction |
Harkness, J.R.;Sabatine, M.S.;Braunwald, E.;Morrow, D.A.;Sloan, S.;Wiviott, S.D.;Giugliano, R.P.;Antman, E.M.;Cannon, C.P.;Scirica, B.M.; |
American Heart Journal |
2010-01-01 |
查看 |
| Early dynamic risk stratification with baseline troponin levels and90-minute ST-segment resolution to predict 30-day cardiovascular mortalityin ST-segment elevation myocardial infarction: Analysis from CLopidogrel asAdjunctive ReperfusIon TherapY (CLARITY) - Thrombolysis in MyocardialInfarction (TIMI) 28 |
Sherwood, M.W.;Morrow, D.A.;Scirica, B.M.;Jiang, S.;Bode, C.;Rifai, N.;Gerszten, R.E.;Gibson, C.M.;Cannon, C.P.;Braunwald, E.;Sabatine, M.S.; |
American Heart Journal |
2010-06-01 |
查看 |
| Assessment of adiponectin and the risk of recurrent cardiovascularevents in patients presenting with an acute coronary syndrome: Observationsfrom the Pravastatin Or atorVastatin Evaluation and InfectionTrial-Thrombolysis in Myocardial Infarction 22 (PROVE IT-TIMI 22) |
Wilson, S.R.;Sabatine, M.S.;Wiviott, S.D.;Ray, K.K.;De Lemos, J.A.;Zhou, S.;Rifai, N.;Cannon, C.P.;Morrow, D.A.; |
American Heart Journal |
2011-06-01 |
查看 |
| Impact of smoking on antiplatelet effect of clopidogrel and prasugrelafter loading dose and on maintenance therapy |
Hochholzer, W.;Trenk, D.;Mega, J.L.;Morath, T.;Stratz, C.;Valina, C.M.;O'Donoghue, M.L.;Bernlochner, I.;Contant, C.F.;Guo, J.;Sabatine, M.S.;Schomig, A.;Neumann, F.J.;Kastrati, A.;Wiviott, S.D.;Sibbing, D.; |
American Heart Journal |
2011-09-01 |
查看 |
| Design and rationale of the Treatment of Acute Coronary Syndromes withOtamixaban trial: A double-blind triple-dummy 2-stage randomized trialcomparing otamixaban to unfractionated heparin and eptifibatide innon-ST-segment elevation acute coronary syndromes with a planned earlyinvasive strategy |
Steg, P.G.;Mehta, S.R.;Pollack, C.V.;Bode, C.;Gaudin, C.;Fanouillere, K.;Moryusef, A.;Wiviott, S.D.;Sabatine, M.S.; |
American Heart Journal |
2012-12-01 |
查看 |
| Balancing the risk of mortality and major bleeding in the treatment ofNSTEMI patients - A report from the National Cardiovascular Data Registry |
Desai, N.R.;Peterson, E.D.;Chen, A.Y.;Wiviott, S.D.;Sabatine, M.S.;Alexander, K.P.;Roe, M.T.;Shah, B.R.; |
American Heart Journal |
2013-12-01 |
查看 |
| Rationale and design of the Further cardiovascular OUtcomes Researchwith PCSK9 Inhibition in subjects with Elevated Risk trial |
Sabatine, M.S.;Giugliano, R.P.;Keech, A.;Honarpour, N.;Wang, H.;Liu, T.;Wasserman, S.M.;Scott, R.;Sever, P.S.;Pedersen, T.R.; |
American Heart Journal |
2016-03-01 |
查看 |
| Rationale and design of the Further cardiovascular OUtcomes Researchwith PCSK9 Inhibition in subjects with Elevated Risk trial |
Sabatine, M.S.;Giugliano, R.P.;Keech, A.;Honarpour, N.;Wang, H.;Liu, T.;Wasserman, S.M.;Scott, R.;Sever, P.S.;Pedersen, T.R.; |
American Heart Journal |
2016-03-01 |
查看 |
| The China Acute Myocardial Infarction (CAMI) Registry: A nationallong-term registry-research-education integrated platform for exploringacute myocardial infarction in China |
CAMI Registry study group;Xu, H.;Li, W.;Yang, J.;Wiviott, S.D.;Sabatine, M.S.;Peterson, E.D.;Xian, Y.;Roe, M.T.;Zhao, W.;Wang, Y.;Tang, X.;Jia, X.;Wu, Y.;Gao, R.;Yang, Y.; |
American Heart Journal |
2016-05-01 |
查看 |
|
|
|
